U.S. FDA Approves Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory ...

Retrieved on: 2025-06-09 19:27:31

Tags for this article:

Click the tags to see associated articles and topics

U.S. FDA Approves Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory .... View article details on hiswai:

Excerpt

June 9, 2025 3:11 pm ET. ENFLONSIA is a preventive monoclonal antibody designed to protect infants against a spectrum of RSV disease severity, ...

Article found on: www.merck.com